Trial intelligence / Profile preview

Ovulation induction therapies for infertility in polycystic ovary syndrome

ChiCTR-TRC-11001821Phase 4Completed

Sponsor
West China Second University Hospital
Start
Oct 2011
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of letrozole, clomiphene and metformin in polycystic ovary syndrome (PCOS) (4 arms), sponsored by West China Second University Hospital. Primary endpoints: Ovulation rate, Pregnancy rate and 1 more. Started Oct 2011; status: completed.

02

Drugs

letrozoleclomiphenemetformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on ChiCTR-TRC-11001821.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001821.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call